Human papillomavirus (HPV) testing isn’t likely to replace conventional Pap tests as a cervical cancer screening tool among women older than 30, a new report suggests. The U.S. Preventive Services Task Force published recommendations for cervical cancer screening in 2003, and researchers are now seeking to fine-tune these guidelines. The results from two evidence reviews, both published Oct. 18 in the Annals of Internal Medicine, seek to clarify and improve upon these guidelines.
